Glucagon-Like Peptide-1 Receptor Agonists Improve MASH and Liver Fibrosis: A Meta-Analysis of Randomised Controlled Trials.

Liver Int · 2025 · PMC12309150 · PMID 40736113

Europe PMC DOI

hedged sentence

0.0590

closest p · 1.2× alpha

0.0590

boldest claim

The sentences

marginally significantp = 0.059so close (0.05 < p ≤ 0.1)

These meta‐regression analyses suggested that sex, age, BMI, pre‐existing T2DM, and percentage changes in body weight during the trial did not significantly affect the effect size for the GLP‐1RA‐induced reduction in liver fat content, although the influence of body weight change during the trial was marginally significant ( p = 0.059).

also in 26,082 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.